Lindsay Rosenwald

Dr. Lindsay Rosenwald is one of the most prolific leaders in the contemporary biotechnology field. His contributions of the research and development of the biotechnology has been enormous and incredible. The Paramount Group companies have contributed a lot to the pharmaceutical and biotechnology field under the dynamic leadership of the Dr. Lindsay Rosenwald. With wide range of the companies under the Paramount Group, he has been the most influential leader in the Wall Street, New York. Dr.Lindsay Rosenwald believes in the small and medium scale companies as he feels that small companies are the backbone of any industry. With this intent, he stated numerous companies that devoted to drug development and clinical research and funded numerous companies at the early stages. The first venture Paramount BioCapital was founded in 1992 and has been growing its wings in the biotechnology industry. BioCapital is a fund rising company which has raised approximately one billion dollars for its group companies. With the diversified experience in biotechnology and finance, he handles wide range of financial portfolio includes venture capitalist, hedge fund and capital asset management. Paramount Capital Management is one company which is into venture capital management.

He completed his finance degree from Pennsylvania State University in 1977. After that he moved to Templeton University School of Medicine to receive his medical degree and he got the medical degree in 1983. He has done his internship work at Abington Medical Hospital. After completion of the internship, he started his own medical practice and ran it successfully for two years before moving to the Wall Street to pursue the career in the advanced research in the biotechnology. Once he moved to the biotechnology, he has done extensive research on biotechnology and started numerous companies in the same field. It is not exaggeration to say that he has changed the fate of biotechnology in the country.

Dr. Rosenwald has been serving as the director for numerous of public and private limited companies around the world. He is the founder of the Rosenwald Foundation, which is a charitable foundation that is completely devoted into the advanced research on biotechnology. Dr. Lindsay Rosenwald has been credited for the fast FDA approvals for marketing the drugs. It is no surprise to say that one of the paramount group companies has developed a rare drug called Arsenic trioxide has got the FDA approval to market with just 30 months of clinical trails. Johnson and Johnson has bought a company called Cougar biotechnologies recently for the terrific amount of one billion dollar and this company has been founded by none other then Dr. Lindsay Rosenwald.

Make a Free Website with Yola.